Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
2010
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
2016 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
1999
Inflammation and cancer
2002 StandoutNature
INTRAOPERATIVE, PERIOPERATIVE, AND LONG-TERM COMPLICATIONS OF RADICAL PROSTATECTOMY
2001
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
2011
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
The Influence of Hospital Volume on Survival after Resection for Lung Cancer
2001
mRNA
2013
Cancer immunotherapy via dendritic cells
2012 Standout
National Trends in Utilization and In-Hospital Outcomes of Bariatric Surgery
2002
ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology
2012
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Trial watch
2013
Cancer Volume of Lymph Node Metastasis Predicts Progression in Prostate Cancer
1998
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Variations in Morbidity after Radical Prostatectomy
2002
Surgeon Volume and Operative Mortality in the United States
2003 Standout
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Loss of T-cell receptor-CD3ζ and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma
2001
Induction of angiogenesis during the transition from hyperplasia to neoplasia
1989 StandoutNature
Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
2016 StandoutNobel
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 Standout
Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
2013
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy
2013
Bladder cancer
2016 Standout
Tuberous sclerosis
2008 Standout
Prostate-Specific Antigen Levels in the United States: Implications of Various Definitions for Abnormal
2005
Apoptosis
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Teaching Surgical Skills — Changes in the Wind
2006 Standout
Chemokines in cancer
2002
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Engineering patient-specific cancer immunotherapies
2019
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Molecular mechanisms of caspase regulation during apoptosis
2004 Standout
Trends in Hospital Volume and Operative Mortality for High-Risk Surgery
2011 Standout
Prognostic value of tumor‐infiltrating dendritic cells expressing CD83 in human breast carcinomas
2003
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 Standout
Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis
2011
Targeting autophagy in cancer
2017 Standout
Relation of Hospital Volume to Colostomy Rates and Survival for Patients With Rectal Cancer
2003
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer
2001
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Defining CD95 as a tumor suppressor gene
2000
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Fas Ligand-Induced Apoptosis
1999
The Three Es of Cancer Immunoediting
2004 Standout
Zygomycetes in Human Disease
2000 Standout
Bladder Cancer
2020 Standout
Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging
1985
Immunotherapy for renal cell cancer in the era of targeted therapy
2008
Thermal Ablation Therapy for Focal Malignancy
2000 Standout
Provider volume and outcomes for oncological procedures
2005
The Tuberous Sclerosis Complex and its Highly Variable Manifestations
2003
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Prognosis of Untreated Stage A1 Prostatic Carcinoma: A Study of 94 Cases with Extended Followup
1986
Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder
1980
Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer
2007
Prognostic Factors in Men with Stage D1 Prostate Cancer: Identification of Patients Less Likely to Have Prolonged Survival After Radical Prostatectomy
1994
Intraperitoneal Cisplatin with Systemic Thiosulfate Protection
1982
Immunotherapy for metastatic renal cell carcinoma
2007
Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature
2002
Clinical significance of poor CD3 response in head and neck cancer.
2002
The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate
1988
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Fas counter-attack–the best form of tumor defense?
1999
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids
2003 Standout
Works of John A. Heaney being referenced
Fatal Genitourinary Mucormycosis in a Patient with Undiagnosed Diabetes
1995
Electrical Impedance Spectroscopy of the Human Prostate
2007
Theoretical and experimental analysis of air cooling for intracavitary microwave hyperthermia applicators
1994
Occupation and Bladder Cancer Risk in a Population-based Case-control Study in New Hampshire
2004
Surgical Treatment of Verrucous Carcinoma of the Bladder Unassociated With Bilharzial Cystitis: Case Report and Literature Review
1995
Tissue-shrinkage Correction Factor in the Calculation of Prostate Cancer Volume
1996
Nodal Involvement as A Prognostic Indicator in Patients with Prostatic Carcinoma
1980
The Effect of Intravesical Thio-tepa on Normal and Tumor Urothelium
1978
Angiographic Management of Retroperitoneal Hemorrhage from Renal Angiomyolipoma in Polycystic Kidney Disease
1991
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
2009
IN VIVO DESCRIPTION OF DENDRITIC CELLS IN HUMAN RENAL CELL CARCINOMA
1999
Multifocal Pigmentation of Prostatic and Bladder Urothelium
1986
Prognosis of Clinically Undiagnosed Prostatic Carcinoma and the Influence of Endocrine Therapy
1977
Postoperative radiation therapy for muscle‐invading bladder carcinoma
1983
Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma.
1998
Developing a Rational Tumor Vaccine Therapy for Renal Cell Carcinoma: Immune Yin and Yang
2007
THE EFFECT OF HOSPITAL VOLUME ON MORTALITY AND RESOURCE USE AFTER RADICAL PROSTATECTOMY
2000
Biopsy of Apparently Normal Urothelium in Patients with Bladder Carcinoma
1978
T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma.
1997